Canadian Government Should Not Be Swayed by U.S. Pharma Lobbying
TORONTO STAR - February 7, 2005 - Michael Geist, Dean of E-Commerce Law at the University of Ottawa, advocates an honest, rational approach to the increasingly litigious issue of Canadian Internet pharmacies. The Canadian government, he argues, should not be influenced by U.S.Pharma's discredited arguments when deciding the future of drug reimportation. Read Article

Drugs Far Cheaper In Canada Than U.S.
ASSOCIATED PRESS - Nov 6, 2003, WASHINGTON - Whether Americans opt for Nexium or Prevacid to treat their heartburn, they could have bought the drugs in Canada for less than half the price. Read Article

Rep. Gil Gutknecht, Special to Insight
INSIGHT MAGAZINE - Sept. 1, 2003 - Q: Have pharmaceutical companies been unfair to American consumers?; Yes: Americans should not have to pay significantly more for the same prescription drugs as our friends in Canada and Europe. Read Article

AARP Endorses Prescription Drugs from Canada
On August 6, 2003, William D. Novelli, the CEO of AARP, issued a letter announcing a decision by AARP to officially endorse the "re-importation" of prescription drugs from Canada. In his letter, Mr. Novelli stated that "carefully crafted re-importation provisions can be a step in [the] direction of finding ways to make prescription drugs more affordable for older Americans." Read Article

Congressional Study Confirms Quality of Canada Drug System
Congressional Study Confirms Quality of Canadian Drug System On May 28, 2003, at the request of members of the U.S. Congress, the Congressional Research Service published an analysis that confirms that the Canadian prescription drug regulatory system is substantially equivalent to that of the United States in all material respects. Read Article

Call us toll-free at 1-866-558-8705,
TTY 1-877-425-2037 (Service for the Deaf)
or FAX at 1-888-431-1185